4.6 Article

Passage Variation of PC12 Cells Results in Inconsistent Susceptibility to Externally Induced Apoptosis

Journal

ACS CHEMICAL NEUROSCIENCE
Volume 8, Issue 1, Pages 82-88

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acschemneuro.6b00208

Keywords

PC12 cells; neuroprotection assay; screening; cell viability; protocol; apoptosis

Funding

  1. National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR001105]
  2. Rare Genomics Institute and Collaborative Drug Discovery

Ask authors/readers for more resources

The PC12 cell line is a widely used in vitro model for screening the neuroprotective activity of small molecule libraries. External insult due to serum deprivation or addition of etoposide induces cell death by apoptosis. While this screening method is commonly used in early stage drug discovery no protocol accounting for cell passage number effect on neuroprotective activity has been disclosed. We herein report that passage variation results in false-positive/false-negative identification of neuroprotective compounds; undifferentiated PC12 cells with high passage number are less sensitive to injury induced by serum deprivation or etoposide treatment. In contrast, NGF differentiated PC12 cells of later passage number are more sensitive to injury induced by etoposide than lower passage number but only after 72 h. Passage number also affects the adherence phenotype of the PC12 cells, complicating screening assays. We report an optimized protocol for screening the neuroprotective activity of small molecules in PC12 cells, which accounts for passage number variations.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Chemistry, Medicinal

Amide Bond Bioisosteres: Strategies, Synthesis, and Successes

Shikha Kumari, Angelica Carmona, Amit K. Tiwari, Paul C. Trippier

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Review Oncology

Tailored Quinolines Demonstrate Flexibility to Exert Antitumor Effects through Varied Mechanisms-A Medicinal Perspective

Sachin Sharma, Arshdeep Singh, Sahil Sharma, Ram Sharma, Jagjeet Singh, Nihar Kinarivala, Kunal Nepali, Jing P. Liou

Summary: Quinoline, a privileged heterocyclic ring, has shown substantial antiproliferative effects through diverse mechanisms of actions in anticancer compounds. Its flexibility and accessibility to structural changes make it a promising option for chemically distinct anti-tumor constructs.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

Discovery of Halogenated Benzothiadiazine Derivatives with Anticancer Activity**

Bader I. Huwaimel, Myla Bhakta, Chaitanya A. Kulkarni, Alexander S. Milliken, Feifei Wang, Aimin Peng, Paul S. Brookes, Paul C. Trippier

Summary: Study investigated benzothiadiazine derivatives for CII inhibition and their impact on cancer cells, identifying compounds with greater antineoplastic effect in triple-negative breast cancer cells compared to clinical agents. No correlation found between cytotoxicity and CII inhibition, suggesting undefined mechanism of action for this scaffold.

CHEMMEDCHEM (2021)

Article Chemistry, Medicinal

Discovery of First-in-Class Peptidomimetic Neurolysin Activators Possessing Enhanced Brain Penetration and Stability

Md Shafikur Rahman, Shikha Kumari, Shiva Hadi Esfahani, Saeideh Nozohouri, Srinidhi Jayaraman, Nihar Kinarivala, Joanna Kocot, Andrew Baez, Delaney Farris, Thomas J. Abbruscato, Vardan T. Karamyan, Paul C. Trippier

Summary: Upregulation of Nln has been identified as a critical endogenous cerebroprotective mechanism after stroke, making it a potential target for the treatment of ischemic stroke. Discovery and optimization of first-in-class Nln activators based on histidine-containing dipeptide hits have led to compounds with improved brain penetration, stability, and potency for drug discovery efforts.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Correction Chemistry, Medicinal

Discovery of First-in-Class Peptidomimetic Neurolysin Activators Possessing Enhanced Brain Penetration and Stability (vol 64, pg 12705, 2021)

Md. Shafikur Rahman, Shikha Kumari, Shiva Hadi Esfahani, Saeideh Nozohouri, Srinidhi Jayaraman, Nihar Kinarivala, Joanna Kocot, Andrew Baez, Delaney Farris, Thomas J. Abbruscato, Vardan T. Karamyan, Paul C. Trippier

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Editorial Material Chemistry, Medicinal

Back to the Medicinal Chemistry Future

Mariateresa Giustiniano, Christian W. Gruber, Caitlin N. Kent, Paul C. Trippier

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Review Biochemistry & Molecular Biology

Patient-Derived Induced Pluripotent Stem Cell Models for Phenotypic Screening in the Neuronal Ceroid Lipofuscinoses

Ahmed Morsy, Angelica Carmona, Paul C. Trippier

Summary: Batten disease or neuronal ceroid lipofuscinosis (NCL) is a group of rare fatal inherited neurodegenerative lysosomal storage disorders for which no curative treatments are currently available. Induced pluripotent stem cells (iPSCs) can serve as valuable models to shed light on disease mechanisms and facilitate drug discovery for NCL.

MOLECULES (2021)

Article Biochemistry & Molecular Biology

Engineering CAR-T cells to activate small-molecule drugs in situ

Thomas J. Gardner, J. Peter Lee, Christopher M. Bourne, Dinali Wijewarnasuriya, Nihar Kinarivala, Keifer G. Kurtz, Broderick C. Corless, Megan M. Dacek, Aaron Y. Chang, George Mo, Kha M. Nguyen, Renier J. Brentjens, Derek S. Tan, David A. Scheinberg

Summary: CAR-T cell therapy is a significant breakthrough in cancer treatment, but currently limited to B cell cancers. Challenges include resistance from antigen-negative tumor cells, immunosuppression in the tumor microenvironment, and T cell exhaustion. A novel class of CAR-T cells has been developed to activate a systemically administered small-molecule prodrug in situ at a tumor site to enhance anticancer activity.

NATURE CHEMICAL BIOLOGY (2022)

Article Chemistry, Organic

Access to Highly Strained Tricyclic Ketals Derived from Coumarins

Sravan K. Jonnalagadda, Bader Huwaimel, Shirisha Jonnalagadda, Jered C. Garrison, Paul C. Trippier

Summary: In this study, the synthesis of highly strained fused substituted dihydrobenzopyran cyclopropyl lactones derived from coumarin carboxylates was reported. The substrate scope was found to tolerate a variety of 6- and 8-substituents on the coumarin ring. However, substitution at the 5- or 7-position was resistant to tricyclic lactone formation, except when 7-methyl substitution was present. A plausible mechanism involving intramolecular rearrangement of trans cyclopropyl methyl ketones with phenolic acetate to form a hemiacetal was proposed for the formation of the fused lactone.

JOURNAL OF ORGANIC CHEMISTRY (2022)

Article Chemistry, Medicinal

Selective carbonic anhydrase IX and XII inhibitors based around a functionalized coumarin scaffold

Bader I. Huwaimel, Sravan K. Jonnalagadda, Shirisha Jonnalagadda, Shikha Kumari, Alessio Nocentini, Claudiu T. Supuran, Paul C. Trippier

Summary: Inhibition of specific carbonic anhydrase (CA) enzymes is a validated strategy for targeting cancer. CA isoforms IX and XII are overexpressed in human solid tumors and play a critical role in regulating tumor acidification, proliferation, and progression. Novel sulfonamides based on the coumarin scaffold were designed and synthesized as potent and selective CA inhibitors, with some compounds showing high inhibition activity against tumor-associated CA IX and CA XII.

DRUG DEVELOPMENT RESEARCH (2023)

Editorial Material Chemistry, Medicinal

Excellence in Medicinal Chemistry: Celebrating ACS Medicinal Chemistry Division (MEDI) Awards. A Call for Nominations

Maria-Jesus Blanco, Amanda Bryant-Friedrich, Gunda Georg, Amjad Ali, Paul L. L. Ornstein, Lori Ferrins, Paul C. C. Trippier

Summary: The American Chemical Society Division of Medicinal Chemistry (MEDI) awards achievements in medicinal chemistry through a variety of awards, fellowships, and honors. In celebration of the Gertrude Elion Medical Chemistry Award, the ACS MEDI Division wishes to inform the community about the numerous awards, fellowships, and travel grants available to members.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Editorial Material Chemistry, Medicinal

Excellence in Medicinal Chemistry: Celebrating ACS Medicinal Chemistry Division (MEDI) Awards. A Call for Nominations

Maria-Jesus Blanco, Amanda Bryant-Friedrich, Gunda Georg, Amjad Ali, Paul L. Ornstein, Lori Ferrins, Paul C. Trippier

Summary: The American Chemical Society Division of Medicinal Chemistry (MEDI) bestows a range of awards, fellowships, and honors to acknowledge outstanding contributions in medicinal chemistry. In celebration of the creation of the Gertrude Elion Medical Chemistry Award, the ACS MEDI Division aims to inform the community about the various available awards, fellowships, and travel grants for members.

ACS MEDICINAL CHEMISTRY LETTERS (2023)

Article Chemistry, Medicinal

Aldo-Keto Reductase 1C3 Inhibitor Prodrug Improves Pharmacokinetic Profile and Demonstrates In Vivo Efficacy in a Prostate Cancer Xenograft Model

Krishnaiah Maddeboina, Sravan K. Jonnalagadda, Ahmed Morsy, Ling Duan, Yashpal S. Chhonker, Daryl J. Murry, Trevor M. Penning, Paul C. Trippier

Summary: AKR1C3 is overexpressed in castration-resistant prostate cancer and drives proliferation and aggressiveness by producing androgens. The study reports the optimization of AKR1C3 inhibitors and the discovery of a potent inhibitor, 5r, with high selectivity for AKR1C3. A prodrug strategy was used to improve pharmacokinetics, and the prodrug 4r was converted to the active form, 5r. In vivo experiments showed increased exposure and concentration of 5r compared to direct administration of the free acid. The prodrug 4r effectively reduced tumor volume without toxicity.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Review Biochemistry & Molecular Biology

The evolution of small molecule enzyme activators

Louise F. Dow, Alfie M. Case, Megan P. Paustian, Braeden R. Pinkerton, Princess Simeon, Paul C. Trippier

Summary: Enzyme activation has emerged as a new mechanism for therapeutic discovery. This article reviews the identification and advancement of non-kinase enzyme activators and their potential in treating various diseases.

RSC MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

An iPSC-Derived Neuron Model of CLN3 Disease Facilitates Small Molecule Phenotypic Screening

Nihar Kinarivala, Ahmed Morsy, Ronak Patel, Angelica Carmona, Md Sanaullah Sajib, Snehal Raut, Constantinos M. Mikelis, Abraham Al-Ahmad, Paul C. Trippier

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)

No Data Available